M&A Deal Summary

Sinocare Acquires Trividia Health

On January 7, 2016, Sinocare acquired medical products company Trividia Health from Nipro for 273M USD

Acquisition Highlights
  • This is Sinocare’s 1st transaction in the Medical Products sector.
  • This is Sinocare’s largest (disclosed) transaction.
  • This is Sinocare’s 1st transaction in the United States.
  • This is Sinocare’s 1st transaction in Florida.

M&A Deal Summary
Date 2016-01-07
Target Trividia Health
Sector Medical Products
Buyer(s) Sinocare
Sellers(s) Nipro
Deal Type Divestiture
Deal Value 273M USD

Target

Trividia Health

Fort Lauderdale, Florida, United States
Trividia Health, Inc. is a manufacturer and marketer of blood glucose monitoring products and diabetes management supplies that are available in national chains and through mail order pharmacies.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sinocare

Changsha, China
Category Company
Founded 2002
Sector Medical Products
Employees4,531
Revenue 4.1B CNY (2023)
DESCRIPTION

Sinocare is a developer of biosensor technology. The Company promotes diabetic self-management by using blood glucose monitoring systems, providing total diabetes services and solutions. Sinocare Group was founded in 2002 and is based in Changsha, China.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 2
Type (Divestiture) 1 of 1
State (Florida) 1 of 1
Country (United States) 1 of 2
Year (2016) 1 of 2
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-02 PTS Diagnostics

Whitestown, Indiana, United States

PTS Diagnostics designs, manufactures, distributes and markets products for distribution. PTS Diagnostics is an innovative, global, point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decision. PTS Diagnostics was founded in 1992 and is based in Whitestown, Indiana.

Buy $200M

Seller(S) 1

SELLER

Nipro

Osaka, Japan
Category Company
Founded 1947
Sector Medical Products
Employees38,117
Revenue 586.8B JPY (2024)
DESCRIPTION

Nipro is engaged directly and through its subsidiaries principally in the development, manufacture and sale of medical devices, pharmaceutical products and medical and glass products. Nipro’s medical device division is engaged in the manufacture and sale of medical devices and its related products, the development, manufacture and sale of cell culturing-related products, as well as the development and sale of diabetes-related products. Nipro was founded in 1947 and is based in Osaka, Japan.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Florida) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-11 Infraredx

Burlington, Massachusetts, United States

Infraredx, Inc. is an intravascular medical device company committed to advancing the diagnosis and management of coronary artery disease globally.

Buy -
Mergr

Product

Company

Legal